Last updated: 2026-10-13 19:06:00. Prices reflect the latest regular market data. Stock price data is sourced from Massive.
Edwards Lifesciences Corp. (EW) operates in the ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES sector and is listed on NYSE. The stock is currently priced at $85.79, with a market capitalisation of $49.12B and a P/E ratio of 49.55. Over the past 52 weeks, its price has ranged from $72.30 to $96.29. This page covers its latest market performance, valuation, price trends and company information.
$49.12B | |
$86.55 | |
$131.73 | |
$2.23 | |
$86.39 | |
1.41M | |
3.82M | |
49.55 | |
$96.29 | |
$72.30 | |
-- | |
-- |
Edwards Lifesciences Corp. (EW) is currently trading at $85.79 as of 2026-10-13 18:50:56, down 0.70% ($0.61) from the previous close of $86.39
During today's regular trading session, EW has traded between $2.23 and $131.73, with a trading volume of 1.41M shares. The current price is near the middle of today's range.
Over the past seven days, Edwards Lifesciences Corp. (EW) moved from $85.15 to $85.79, representing a gain of 0.75% ($0.63).
The stock traded between $82.43 and $87.88 during the period. The latest price is near the middle of the 7-day range, indicating moderate upward.
The average daily volume was 3.76 million shares, up versus the previous seven-day period, indicating higher trading activity.
Position in Range: 56.2%
EW is currently trading at $85.79, placing it 56.2% of the way from its 52-week low of $72.30 to its 52-week high of $96.29. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Spun off from Baxter International in 2000, Edwards Lifesciences designs, manufactures, and markets a range of medical devices and equipment for advanced stages of structural heart disease. It has established itself as a leader across key products, including surgical tissue heart valves, transcatheter aortic valves, and transcatheter mitral and tricuspid valve technologies. The firm derives about 60% of its total sales from outside the US.
| Industry | ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES |
| Employees | 16000 |
| Exchange | NYSE |
| Company Website |
Eligible investors can buy real shares of Edwards Lifesciences Corp. (EW) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.